Human Placenta and Evolving Insights into Pathological Changes of Preeclampsia: A Comprehensive Review of the Last Decade

References

• Turco MY, Moffett A. Development of the human placenta. Development. 2019 Nov;146(22):dev163428. doi:10.1242/dev.163428.
   PubMed Web of Science ®Google Scholar
• Yu N, Wu JL, Xiao J, Fan L, Chen SH, Li W. HIF-1α regulates angiogenesis via Notch1/STAT3/ETBR pathway in trophoblastic cells. Cell Cycle. 2019;18(24):3502–12. doi:10.1080/15384101.2019.1689481.
   PubMed Web of Science ®Google Scholar
• Roland CS, Hu J, Ren CE, Chen H, Li J, Varvoutis MS, Leaphart LW, Byck DB, Zhu X, Jiang SW, et al. Morphological changes of placental syncytium and their implications for the pathogenesis of preeclampsia. Cell Mol Life Sci. 2016;73(2):365–76. doi:10.1007/s00018-015-2069-x.
   PubMed Web of Science ®Google Scholar
• Zullino S, Di Martino D, Stampalija T, Ferrazzi E. New lenses to look at preeclampsia. Gynecol Endocrinol. 2016 Nov;32(2):87–90. doi:10.3109/09513590.2015.1115833.
   PubMed Web of Science ®Google Scholar
• Jena MK, Sharma NR, Petitt M, Maulik D, Nayak NR. Pathogenesis of preeclampsia and therapeutic approaches targeting the placenta. Biomolecules. 2020 Jun ;10(6):953. doi:10.3390/biom10060953.
   PubMed Web of Science ®Google Scholar
• Phipps EA, Thadhani R, Benzing T, Karumanchi SA. Preeclampsia: pathogenesis, novel diagnostics, and therapies. Nat Rev Nephrol. 2019 Jun;15(5):275–89. doi:10.1038/s41581-019-0119-6.
   PubMed Web of Science ®Google Scholar
• Fillion A, Guerby P, Menzies D, Lachance C, Comeau M-P, Bussières M-C, Doucet-Gingras F-A, Zérounian S, Bujold E. Pathological investigation of placentas in preeclampsia (the PEARL study). Hypertens Pregnancy. 2021 Feb;40(1):56–62. doi:10.1080/10641955.2020.1866008.
   PubMed Web of Science ®Google Scholar
• Nirupama R, Divyashree S, Janhavi P, Muthukumar SP, Ravindra PV. Preeclampsia: pathophysiology and management. J Gynecol Obstet Hum Reprod. 2021 Nov;50(2):101975. doi:10.1016/j.jogoh.2020.101975.
   PubMed Web of Science ®Google Scholar
• Weiner E, Feldstein O, Tamayev L, Grinstein E, Barber E, Bar J, Schreiber L, Kovo M. Placental histopathological lesions in correlation with neonatal outcome in preeclampsia with and without severe features. Pregnancy Hypertens. 2018 Apr;12:6–10. doi:10.1016/j.preghy.2018.02.001.
   PubMed Web of Science ®Google Scholar
• Tomimatsu T, Mimura K, Endo M, Kumasawa K, Kimura T. Pathophysiology of preeclampsia: an angiogenic imbalance and long-lasting systemic vascular dysfunction. Hypertens Res. 2017 Apr;40(4):305–10. doi:10.1038/hr.2016.152.
   PubMed Web of Science ®Google Scholar
• Falco ML, Sivanathan J, Laoreti A, Thilaganathan B, Khalil A. Placental histopathology associated with preeclampsia: systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2017 Sep;50(3):295–301. doi:10.1002/uog.17494.
   PubMed Web of Science ®Google Scholar
• Travaglino A, Raffone A, Saccone G, Migliorini S, Maruotti GM, Esposito G, Mollo A, Martinelli P, Zullo F, D'Armiento M, et al. Placental morphology, apoptosis, angiogenesis and epithelial mechanisms in early-onset preeclampsia. Eur J Obstet Gynecol Reprod Biol. 2019 Mar;234:200–6. doi:10.1016/j.ejogrb.2018.12.039.
   PubMed Web of Science ®Google Scholar
• Turbeville HR, Sasser JM. Preeclampsia beyond pregnancy: long-term consequences for mother and child. Am J Physiol Renal Physiol. 2020 Jun;318(6):F1315–26. doi:10.1152/ajprenal.00071.2020.
   PubMed Web of Science ®Google Scholar
• Tossetta G, Fantone S, Giannubilo SR, Marinelli Busilacchi E, Ciavattini A, Castellucci M, Di Simone N, Mattioli-Belmonte M, Marzioni D. Preeclampsia onset and SPARC: a possible involvement in placenta development. J Cell Physiol. 2019 Aug;234(5):6091–8. doi:10.1002/jcp.27344.
   PubMed Web of Science ®Google Scholar
• Ramos JGL, Sass N, Costa SHM. Preeclampsia. Pré-eclâmpsia. Rev Bras Ginecol Obstet. 2017 Sep;39(9):496–512. doi:10.1055/s-0037-1604471.
   PubMedGoogle Scholar
• Ma’ayeh M, Costantine MM. Prevention of preeclampsia. Semin Fetal Neonatal Med. 2020 Oct;25(5):101123. doi:10.1016/j.siny.2020.101123.
   PubMed Web of Science ®Google Scholar
• Hu M, Li J, Baker PN, Tong C. Revisiting preeclampsia: a metabolic disorder of the placenta. Febs J. 2022 Jan;289(2):336–54. doi:10.1111/febs.15745.
   PubMed Web of Science ®Google Scholar
• Pereira MM, Torrado J, Sosa C, Zócalo Y, Bia D. Role of arterial impairment in preeclampsia: should the paradigm shift? Am J Physiol Heart Circ Physiol. 2021 May;320(5):H2011–30. doi:10.1152/ajpheart.01005.2020.
   PubMed Web of Science ®Google Scholar
• Myatt L. The prediction of preeclampsia: the way forward. Am J Obstet Gynecol. 2022 Feb;226(2S):S1102–7.e8. doi:10.1016/j.ajog.2020.10.047.
   PubMedGoogle Scholar
• Carrasco-Wong I, Aguilera-Olguín M, Escalona-Rivano R, Chiarello DI, Barragán-Zúñiga LJ, Sosa-Macías M, Galaviz-Hernandez C, San Martín S, Gutiérrez J. Syncytiotrophoblast stress in early onset preeclampsia: the issues perpetuating the syndrome. Placenta. 2021 Sep;113:57–66. doi:10.1016/j.placenta.2021.05.002.
   PubMed Web of Science ®Google Scholar
• Sferruzzi-Perri AN, Camm EJ. The programming power of the placenta. Front Physiol. 2016 Mar;7:33. doi:10.3389/fphys.2016.00033.
   PubMed Web of Science ®Google Scholar
• Ridder A, Giorgione V, Khalil A, Thilaganathan B. Preeclampsia: the relationship between uterine artery blood flow and trophoblast function. Int J Mol Sci. 2019 Jul;20(13):3263. doi:10.3390/ijms20133263.
   PubMed Web of Science ®Google Scholar
• Michalczyk M, Celewicz A, Celewicz M, Woźniakowska-Gondek P, Rzepka R. The role of inflammation in the pathogenesis of preeclampsia. Mediators Inflamm. 2020 Oct;2020:3864941–9. doi:10.1155/2020/3864941.
   PubMed Web of Science ®Google Scholar
• Aviram A, Giltvedt MK, Sherman C, Kingdom J, Zaltz A, Barrett J, Melamed N. The role of placental malperfusion in the pathogenesis of preeclampsia in dichorionic twin and singleton pregnancies. Placenta. 2018 Oct;70:41–9. doi:10.1016/j.placenta.2018.09.002.
   PubMed Web of Science ®Google Scholar
• Staff AC. The two-stage placental model of preeclampsia: an update. J Reprod Immunol. 2019 Oct;134–135:1–10. doi:10.1016/j.jri.2019.07.004.
   PubMed Web of Science ®Google Scholar
• Melchiorre K, Giorgione V, Thilaganathan B. The placenta and preeclampsia: villain or victim? Am J Obstet Gynecol. 2022 Feb;226(2S):S954–S962. doi:10.1016/j.ajog.2020.10.024.
   PubMedGoogle Scholar
• Zhang B, Tan L, Yu Y, Wang B, Chen Z, Han J, Li M, Chen J, Xiao T, Ambati BK, et al. Placenta-specific drug delivery by trophoblast-targeted nanoparticles in mice. Theranostics. 2018 Apr;8(10):2765–81. doi:10.7150/thno.22904.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Zheng YF, Luo QQ, Yan T, Liu XX, Han L, Zou L. Edaravone inhibits hypoxia-induced trophoblast-soluble FMS-like tyrosine kinase 1 expression: a possible therapeutic approach to preeclampsia. Placenta. 2014 Jul;35(7):476–82. doi:10.1016/j.placenta.2014.04.002.
   PubMed Web of Science ®Google Scholar
• McDonnold M, Tamayo E, Kechichian T, Gamble P, Longo M, Hankins GDV, Saade GR, Costantine MM. The effect of prenatal pravastatin treatment on altered fetal programming of postnatal growth and metabolic function in a preeclampsia-like murine model. Am J Obstet Gynecol. 2014 Jun;210(6):542.e1–542.e5427. doi:10.1016/j.ajog.2014.01.010.
   PubMed Web of Science ®Google Scholar
• Eddy AC, Bidwell GL, 3rd, George EM. Pro-angiogenic therapeutics for preeclampsia. Biol Sex Differ. 2018 Aug;9(1):36. doi:10.1186/s13293-018-0195-5.
   PubMedGoogle Scholar
• Feng Y, Hu L, Xu Q, Yuan H, Ba L, He Y, Che H. Cytoprotective role of alpha-1 antitrypsin in vascular endothelial cell under hypoxia/reoxygenation condition. J Cardiovasc Pharmacol. 2015 Jul;66(1):96–107. doi:10.1097/FJC.0000000000000250.
   PubMed Web of Science ®Google Scholar
• Saad AF, Diken ZM, Kechichian TB, Clark SM, Olson GL, Saade GR, Costantine MM. Pravastatin effects on placental prosurvival molecular pathways in a mouse model of preeclampsia. Reprod Sci. 2016 Nov;23(11):1593–9. doi:10.1177/1933719116648218.
   PubMed Web of Science ®Google Scholar
• Brosens I, Puttemans P, Benagiano G. Placental bed research: i. The placental bed: from spiral arteries remodeling to the great obstetrical syndromes. Am J Obstet Gynecol. 2019 Nov;221(5):437–56. doi:10.1016/j.ajog.2019.05.044.
   PubMed Web of Science ®Google Scholar
• Rambaldi MP, Weiner E, Mecacci F, Bar J, Petraglia F. Immunomodulation and preeclampsia. Best Pract Res Clin Obstet Gynaecol. 2019 Oct;60:87–96. doi:10.1016/j.bpobgyn.2019.06.005.
   PubMed Web of Science ®Google Scholar
• Hong K, Kim SH, Cha DH, Park HJ. Defective uteroplacental vascular remodeling in preeclampsia: key molecular factors leading to long term cardiovascular disease. Int J Mol Sci. 2021 Oct;22(20):11202. doi:10.3390/ijms222011202.
   PubMed Web of Science ®Google Scholar
• Hu X, Zhang L. Uteroplacental circulation in normal pregnancy and preeclampsia: functional adaptation and maladaptation. Int J Mol Sci. 2021 Aug;22(16):8622. doi:10.3390/ijms22168622.
   PubMed Web of Science ®Google Scholar
• Staff AC, Fjeldstad HE, Fosheim IK, Moe K, Turowski G, Johnsen GM, Alnaes-Katjavivi P, Sugulle M. Failure of physiological transformation and spiral artery atherosis: their roles in preeclampsia. Am J Obstet Gynecol. 2022 Feb;226(2S):S895–S906. doi:10.1016/j.ajog.2020.09.026.
   PubMedGoogle Scholar
• Benagiano M, Mancuso S, Brosens JJ, Benagiano G. Long-term consequences of placental vascular pathology on the maternal and offspring cardiovascular systems. Biomolecules. 2021 Nov;11(11):1625. doi:10.3390/biom11111625.
   PubMed Web of Science ®Google Scholar
• Opichka MA, Rappelt MW, Gutterman DD, Grobe JL, McIntosh JJ. Vascular dysfunction in preeclampsia. Cells. 2021 Nov;10(11):3055. doi:10.3390/cells10113055.
   PubMed Web of Science ®Google Scholar
• Degner K, Magness RR, Shah DM. Establishment of the human uteroplacental circulation: a historical perspective. Reprod Sci. 2017 May;24(5):753–61. doi:10.1177/1933719116669056.
   PubMed Web of Science ®Google Scholar
• Kim JY, Kim YM. Acute atherosis of the uterine spiral arteries: clinicopathologic implications. J Pathol Transl Med. 2015 Nov;49(6):462–71. doi:10.4132/jptm.2015.10.23.
   PubMedGoogle Scholar
• Gu Y, Feng Y, Yu J, Yuan H, Yin Y, Ding J, Zhao J, Xu Y, Xu J, Che H, et al. Fasudil attenuates soluble fms-like tyrosine kinase-1 (sFlt-1)-induced hypertension in pregnant mice through RhoA/ROCK pathway. Oncotarget. 2017 Oct;8(61):104104–12. doi:10.18632/oncotarget.22017.
   PubMedGoogle Scholar
• Ushida T, Kotani T, Tsuda H, Imai K, Nakano T, Hirako S, Ito Y, Li H, Mano Y, Wang J, et al. Molecular hydrogen ameliorates several characteristics of preeclampsia in the Reduced Uterine Perfusion Pressure (RUPP) rat model. Free Radic Biol Med. 2016 Dec;101:524–33. doi:10.1016/j.freeradbiomed.2016.10.491.
   PubMed Web of Science ®Google Scholar
• Brownfoot FC, Hannan NJ, Cannon P, Nguyen V, Hastie R, Parry LJ, Senadheera S, Tuohey L, Tong S, Kaitu’u-Lino TJ, et al. Sulfasalazine reduces placental secretion of antiangiogenic factors, up-regulates the secretion of placental growth factor and rescues endothelial dysfunction. EBioMedicine. 2019 Jun;41:636–48. doi:10.1016/j.ebiom.2019.02.013.
   PubMed Web of Science ®Google Scholar
• Lin L, Li G, Zhang W, Wang YL, Yang H. Low-dose aspirin reduces hypoxia-induced sFlt1 release via the JNK/AP-1 pathway in human trophoblast and endothelial cells. J Cell Physiol. 2019 Aug;234(10):18928–41. doi:10.1002/jcp.28533.
   PubMed Web of Science ®Google Scholar
• Kweider N, Wruck CJ, Rath W. New insights into the pathogenesis of preeclampsia -the role of Nrf2 activators and their potential therapeutic impact. Geburtshilfe Frauenheilkd. 2013 Dec;73(12):1236–40. doi:10.1055/s-0033-1360133.
   PubMed Web of Science ®Google Scholar
• Santiago-Font JA, Amaral LM, Faulkner J, Ibrahim T, Vaka VR, Cunningham MW, LaMarca B. Serelaxin improves the pathophysiology of placental ischemia in the reduced uterine perfusion pressure rat model of preeclampsia. Am J Physiol Regul Integr Comp Physiol. 2016 Dec;311(6):R1158–63. doi:10.1152/ajpregu.00192.2016.
   PubMed Web of Science ®Google Scholar
• McGinnis R, Steinthorsdottir V, Williams NO, Thorleifsson G, Shooter S, Hjartardottir S, Bumpstead S, Stefansdottir L, Hildyard L, Sigurdsson JK, et al. Variants in the fetal genome near FLT1 are associated with risk of preeclampsia. Nat Genet. 2017 Aug;49(8):1255–60. doi:10.1038/ng.3895.
   PubMed Web of Science ®Google Scholar
• Herse F, LaMarca B. Angiotensin II type 1 receptor autoantibody (AT1-AA)-mediated pregnancy hypertension. Am J Reprod Immunol. 2013 Apr;69(4):413–8. doi:10.1111/aji.12072.
   PubMed Web of Science ®Google Scholar
• Jiang WL, Zhang YF, Xia QQ, Zhu J, Yu X, Fan T, Wang F. MicroRNA-19a regulates lipopolysaccharide-induced endothelial cell apoptosis through modulation of apoptosis signal-regulating kinase 1 expression. BMC Mol Biol. 2015 May;16(1):11. doi:10.1186/s12867-015-0034-8.
   PubMedGoogle Scholar
• Stødle GS, Silva GB, Tangerås LH, Gierman LM, Nervik I, Dahlberg UE, Sun C, Aune MH, Thomsen LCV, Bjørge L, et al. Placental inflammation in preeclampsia by Nod-like receptor protein (NLRP)3 inflammasome activation in trophoblasts. Clin Exp Immunol. 2018 Jul;193(1):84–94. doi:10.1111/cei.13130.
   PubMed Web of Science ®Google Scholar
• Shi J, Wei L. Rho kinases in cardiovascular physiology and pathophysiology: the effect of fasudil. J Cardiovasc Pharmacol. 2013 Jul;62(4):341–54. doi:10.1097/FJC.0b013e3182a3718f.
   PubMed Web of Science ®Google Scholar